Based on a 2011 report, an estimated 8.3% of Canadians (2.7 million people) reported having been diagnosed with a migraine. The reason for these moderate to severe headaches is still a relative mystery to the medical community, however thousands of sufferers have found relief with medical cannabis.
Anecdotally, until the 1930’s, American physicians commonly prescribed cannabis as a medicine which was dispensed by the local pharmacy. In England, Queen Victoria’s physicians prescribed Cannabidiol (CBD), the principal non-psychoactive compound in cannabis in the form of CBD based medicines to treat monthly premenstrual syndrome (PMS) symptoms which often include migraines. Thorough research has found CBD to be effective at reducing pain associated with a wide variety of conditions, including the common headache and migraines (Baron, 2015). CBD and the principal psycho-active compound of cannabis, Tetrahydrocannabinol (THC) combinations has shown to be clinically effective at inhibiting the pain response caused by migraines by decreasing prostaglandins release and pro inflammatory molecule inhibition by stabilisation of mast cells granules (Akerman, Holland, Lasalandra & Goardsby, 2013), (Baron, 2015) and (Greco, et al., 2014).
If you or a loved one suffers from migraines, please contact Medical Marijuana Group (MMG) for information on how you can access safe, effective medical cannabis by clicking here.